Nephrologist for Insights on Diet and CKD Prevention This is on a recent study about diet and CKD prevention titled: The EAT–Lancet planetary health diet and risk of incident chronic kidney disease Questions: 1. Why is this study on the EAT–Lancet planetary health diet particularly important for advancing our understanding of CKD prevention at a population level, compared with prior dietary pattern research? 2. The study found that higher adherence to the EAT–Lancet diet was associated with a lower risk of incident CKD, with stronger effects in individuals with low green-space exposure and certain genetic variants. How should clinicians interpret these subgroup findings, and what do they suggest about environmental and biological modifiers of diet–kidney interactions? 3. How can the finding that "Adherence to the EAT–Lancet diet is associated with a lower risk of incident CKD, particularly in individuals with low green-space exposure and specific genetic variants." realistically help guide individualized interventions in CKD prevention? For example, tailoring dietary counseling based on environmental context or genetic risk—without overcomplicating clinical practice.

I'm the CEO of Lifebit, where we build federated platforms that connect genetic, clinical, and real-world data across institutions--so I spend my days thinking about how to turn population-level insights into something clinicians can actually use without drowning in complexity. **The strength of this study isn't the diet itself--it's the stratification.** When we worked with 23andMe on their Find23 platform, we saw the same pattern: genetic associations only become actionable when you layer them with phenotypic and environmental context. The CKD findings show that a one-size-fits-all diet recommendation misses half the story--just like how we've seen cancer drug responses vary wildly based on ancestry and environmental exposures in our pharma collaborations. **Here's what works in practice without genetic testing:** use EHR zip codes and baseline labs to flag high-risk clusters. In our Nordic TRE implementations, clinicians are already linking postal codes to green-space indices and socioeconomic data--it takes zero extra work from the physician. If someone lives in a low-greenspace area with borderline kidney function, that patient gets the intensive dietary intervention protocol, not the generic handout. You're essentially triaging dietary counseling the same way you'd triage a chest pain--context dictates urgency. **The genetic piece becomes useful at scale, not in individual appointments.** When we powered the Lupus Research Alliance data platform, we enabled researchers to identify which patient subgroups responded to interventions--but that analysis happened in the background while clinicians kept prescribing normally. The right move is building systems where genetic risk scores auto-populate flags in the EHR when they're available, so docs see "high diet-responsive genotype" next to the creatinine value. You don't change your workflow; the data infrastructure does the lifting.